Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,017 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Schlumberger N.V. (Schlumberger Limited) KITT Nauticus Robotics, Inc. 13D 17.4% 3y
van Kesteren Foundation JANL Janel Corp 13G 6.9% 3y
ORBIMED ADVISORS LLC APLM Apollomics Inc. 13D/A 18.1% 3y
Saba Capital Management, L.P. EMO ClearBridge Energy Midstream Opportunity Fund Inc. 13D/A 21.86% 3y
Politan Capital Management LP AZTA Azenta, Inc. 13D/A 7.61% 3y
GNI Group Ltd. GYRE Gyre Therapeutics, Inc. 13D/A 85.36% 3y
Ben M. Brigham AESI Atlas Energy Solutions Inc. 13D/A 45.1% 3y
ICAHN CARL C CCK Crown Holdings, Inc. 13D/A 6.7% 3y
Saba Capital Management, L.P. IGA Voya Global Advantage & Premium Opportunity Fund 13D 5.22% 3y
Professional Financial Advisors, LLC AADR AdvisorShares Trust 13G 10% 3y
Ruiyuan Technology Holdings Limited CCG Cheche Group Inc. 13G 5.9% 3y
Magnetar Financial LLC CCV Churchill Capital Corp V 13G/A 0% 3y
Saudi Arabian Mining Company (Ma’aden) IE Ivanhoe Electric Inc. 13D/A 9.9% 3y
SHAH CAPITAL MANAGEMENT VEON VEON Ltd. 13D/A 6.62% 3y
Bertelsmann SE & Co. KGaA AFYA Afya Ltd 13D/A 59.44% 3y
Point72 Asset Management, L.P. SNDX Syndax Pharmaceuticals Inc 13G 5.1% 3y
STILWELL JOSEPH PVBC Provident Bancorp, Inc. (MD) Common Stock 13D/A 10.4% 3y
Fernando Chico Pardo ASR Southeast Airport Group 13D/A 30.67% 3y
EIG Veteran Equity Aggregator, L.P. USAC USA Compression Partners, LP 13D/A 19.3% 3y
Rubric Capital Management LP MREO Mereo BioPharma Group plc 13D/A 13.15% 3y
Edward Smolyansky LWAY Lifeway Foods, Inc. 13D/A 21.2% 3y
Columbus Capital Management, LLC HSDT Solana Co 13G 9.6% 3y
I.B.F Management Ltd. ADXS Advaxis, Inc. 13D/A 28% 3y
Natural Selection Fund I, LP NMPGY Navios Maritime Holdings Inc. 13D 6.57% 3y
Formidable Asset Management, LLC FLUX Flux Power Holdings, Inc. 13D 20.27% 3y
Xiang Li WNW Meiwu Technology Co Ltd 13G 7.91% 3y
Zhendong Zhang WNW Meiwu Technology Co Ltd 13G 8.55% 3y
Xiaolin Zhang WNW Meiwu Technology Co Ltd 13G 7.67% 3y
Naiyun Bi WNW Meiwu Technology Co Ltd 13G 8.15% 3y
Huilin Xu WNW Meiwu Technology Co Ltd 13G 7.19% 3y
First Light Asset Management, LLC OFIX Orthofix Medical Inc. 13G/A 0.25% 3y
Adam London ASTR Astra Space, Inc. Class A Common Stock 13D/A 9.4% 3y
Chris Kemp ASTR Astra Space, Inc. Class A Common Stock 13D/A 9.3% 3y
GAMCO INVESTORS, INC. ET AL INVX Innovex International, Inc. 13D/A 5.73% 3y
Fund 1 Investments, LLC CTRN Citi Trends Inc 13D/A 11.37% 3y
Spear Catherine Eva FIGS FIGS, Inc. 13D/A 12.2% 3y
Philotimo Fund, LP OESX Orion Energy Systems, Inc. 13D/A 4.8% 3y
Hasson Heather L. FIGS FIGS, Inc. 13D/A 9.49% 3y
IMA Value LLP RAVE Rave Restaurant Group, Inc. 13D 5.33% 3y
White Lion Capital, LLC ACON Aclarion, Inc. 13G 5.9% 3y
Deep Track Capital, LP ABVX Abivax S.A. 13G 6.14% 3y
RA CAPITAL MANAGEMENT, L.P. MGNX Macrogenics Inc 13G 6.1% 3y
ELLINGTON MANAGEMENT GROUP LLC RPT Rithm Property Trust Inc. 13G 7.1% 3y
SUVRETTA CAPITAL MANAGEMENT, LLC ARQT Arcutis Biotherapeutics, Inc. 13G 9.99% 3y
HCG Opportunity, LLC CDAQF Compass Digital Acquisition Corp. 13D 36.4% 3y
Qiming U.S. Healthcare Fund II, L.P. TRML Tourmaline Bio, Inc. Common Stock 13D/A 3.2% 3y
Perception Capital Partners II LLC SPEC Spectaire Holdings, Inc. Common Stock 13D 59.6% 3y
Paradigm Biocapital Advisors LP NUVL Nuvalent, Inc. 13G 5.9% 3y
MOORE CAPITAL MANAGEMENT, LP EGOX Next.e.GO N.V. Ordinary Shares 13G 9.3% 3y
SUVRETTA CAPITAL MANAGEMENT, LLC ETNB 89bio, Inc. Common Stock 13G 6.4% 3y